Prospective prevalence estimation of BRCA1, BRCA2, and other germline mutations associated with hereditary pancreatic cancer (HPC) using a comprehensive gene panel in an unselected cohort of Mexican patients with pancreatic ductal adenocarcinoma (PDAC).

被引：0
作者：
Rosas Camargo, Vanessa
Arteaga, Jazmin
Melchor Ruan, Javier
Escorza, Salvador
Cedro-Tanda, Alberto
Vidal, Silvia
Torres Valdiviezo, Lucero Itzel
Cisneros Cordero, Miriam Heidi
Arce Sandoval, Cesar
Meneses Medina, Monica Isabel
Herrera, Marytere
Huitzil Melendez, Fidel David David
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Natl Inst Med Sci & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Mexico City, DF, Mexico
[4] Inst Nacl Med Genom, Mexico City, DF, Mexico
[5] Univ Americas Puebla, Fac Med, Cholula, PU, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10609
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prevalence of BRCA1 and BRCA2 Germline Mutations Among Pakistani Patients With Triple Negative Breast Cancer
    Rashid, M.
    Bajwa, S.
    Muhammad, N.
    Gull, S.
    Faisal, S.
    Amin, A.
    Loya, A.
    Hamann, U.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S254 - S255
  • [42] Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis
    McGarry, Jennifer L.
    Creavin, Ben
    Kelly, Michael E.
    Gallagher, Tom K.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (06) : 1028 - 1037
  • [43] Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
    Peto, J
    Collins, N
    Barfoot, R
    Seal, S
    Warren, W
    Rahman, N
    Easton, DF
    Evans, C
    Deacon, J
    Stratton, MR
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) : 943 - 949
  • [44] Olaparib sensitivity observed in metastatic pancreatic cancer (mPaC) with a wide spectrum of germline BRCA1 and BRCA2 mutations (gBRCAm).
    Golan, Talia
    Kindler, Hedy L.
    Schatz, Philipp
    Goranova, Teodora
    Locker, Gershon Y.
    Cui, Karen
    Schlienger, Katia
    McGuinness, David
    Williams, Andrew J.
    Orr, Maria
    Gutjahr, Thorsten
    Liu Yu-Zhen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [45] Olaparib sensitivity observed in metastatic pancreatic cancer (mPaC) with a wide spectrum of germline BRCA1 and BRCA2 mutations (gBRCAm).
    Golan, Talia
    Kindler, Hedy L.
    Schatz, Philipp
    Goranova, Teodora
    Locker, Gershon Y.
    Cui, Karen
    Schlienger, Katia
    McGuinness, David
    Williams, J. Andrew
    Orr, Maria
    Gutjahr, Thorsten
    Liu, Yu-Zhen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer
    Grant, Robert C.
    Holter, Spring
    Borgida, Ayelet
    Dhani, Neesha C.
    Hedley, David W.
    Knox, Jennifer J.
    Akbari, Mohammad R.
    Zogopoulos, George
    Gallinger, Steven
    [J]. JOURNAL OF GENETIC COUNSELING, 2018, 27 (04) : 988 - 995
  • [47] Olaparib sensitivity observed in metastatic pancreatic cancer (mPaC) with a wide spectrum of germline BRCA1 and BRCA2 mutations (gBRCAm)
    Reinacher-Schick, A.
    Golan, T.
    Kindler, H. L.
    Schatz, P.
    Goranova, T.
    Locker, G. Y.
    Cui, K.
    Schlienger, K.
    McGuinness, D.
    Williams, J. A.
    Orr, M.
    Gutjahr, T.
    Liu, Y-Z
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 214 - 215
  • [48] Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2
    Saldia, Amethyst
    Olson, Sara H.
    Nunes, Pamela
    Liang, Xiaolin
    Samson, Marguerite L.
    Salo-Mullen, Erin
    Marcell, Vanessa
    Stadler, Zsofia K.
    Allen, Peter J.
    Offit, Kenneth
    Kurtz, Robert C.
    [J]. CANCER PREVENTION RESEARCH, 2019, 12 (09) : 599 - 607
  • [49] An analysis of outcomes in patients (pts) with advanced pancreatic cancer (PDAC) whose tumors harbor pathogenic BRCA1 or BRCA2 mutations based on gene mutation location
    Hur, Jamie
    McPhaul, Thomas
    Cunningham, Dea
    Zheng, Lei
    Pishvaian, Christopher J.
    Laheru, Daniel
    De Jesus-Acosta, Ana
    Le, Dung
    Zaidi, Neeha
    Azad, Nilo
    Browner, Ilene
    Burns, William R.
    Burkhart, Richard
    Lafaro, Kelly
    Narang, Amol
    He, Jin
    Lee, Valerie
    Brody, Jonathan R.
    Pishvaian, Michael J.
    [J]. CANCER RESEARCH, 2024, 84 (17)
  • [50] The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients
    Grigore, Liliana-Georgiana
    Radoi, Viorica-Elena
    Serban, Alexandra
    Mihai, Adina Daniela
    Stoica, Ileana
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (05) : 4630 - 4645
12345